SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-023595
Filing Date
2020-12-15
Accepted
2020-12-15 06:25:27
Documents
1
Period of Report
2020-12-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3304
  Complete submission text file 0001493152-20-023595.txt   4851
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address
Sundar Padmavathi (Reporting) CIK: 0001778709 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 201388156